Boothbay Fund Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-61,430
Closed -$3.82M 1995
2023
Q4
$3.82M Sell
61,430
-49,308
-45% -$2.76M 0.1% 284
2023
Q3
$6.21M Sell
110,738
-52,347
-32% -$2.94M 0.15% 157
2023
Q2
$8.23M Buy
163,085
+35,573
+28% +$1.89M 0.18% 104
2023
Q1
$6.96M Buy
127,512
+55,969
+78% +$3.27M 0.14% 154
2022
Q4
$4.47M Buy
+71,543
New +$4.75M 0.1% 272
2022
Q3
Sell
-50,037
Closed -$2.84M 2682
2022
Q2
$2.84M Buy
50,037
+11,161
+29% +$612K 0.07% 403
2022
Q1
$2.43M Buy
38,876
+20,277
+109% +$1.09M 0.06% 495
2021
Q4
$1.04M Buy
+18,599
New +$1.14M 0.02% 726
2021
Q3
Sell
-9,439
Closed -$599K 2257
2021
Q2
$599K Sell
9,439
-5
-0.1% -$295 0.02% 922
2021
Q1
$566K Sell
9,444
-4,909
-34% -$267K 0.02% 872
2020
Q4
$717K Buy
+14,353
New +$674K 0.03% 618
2020
Q3
Sell
-7,929
Closed -$278K 1269
2020
Q2
$278K Sell
7,929
-1,295
-14% -$44.6K 0.02% 717
2020
Q1
$234K Sell
9,224
-2,822
-23% -$83.9K 0.02% 630
2019
Q4
$334K Sell
12,046
-6,367
-35% -$152K 0.03% 585
2019
Q3
$496K Buy
+18,413
New +$641K 0.05% 462

Other funds holding AXNX

Boothbay Fund Management's AXNX Position: Q1 2024 in Review

Boothbay Fund Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 61,430 shares — an estimated $3.82M sold.

Boothbay Fund Management first reported a position in AXNX in Q3 2019 and held it in 15 quarters. The position peaked at $8.23M in Q2 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Boothbay Fund Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 61,430 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $3.82M.
  • Boothbay Fund Management first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 15 quarters.
  • Boothbay Fund Management's Axonics, Inc. Common Stock position peaked at $8.23M in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.